
Patients have been raising concerns about the negative effects of copay accumulators, maximizers, and alternative funding programs. New research is shining more light on their harmful impact on patients' access to treatment, care experience, and health.
Join the National Pharmaceutical Council on Thursday, April 17, from 2:30 to 3:30 PM ET, for a discussion with researchers and patient leaders on the rise of these controversial "cost-shifting" programs, their effects on patients, and policy actions to curtail them. Audience Q&A will follow the panel discussion.
![]() | ![]() |
Kim CzubarukAssociate Vice President of Policy CancerCare
| Carl SchmidExecutive Director HIV+Hepatitis Policy Institute
|
![]() | ![]() |
Kimberly WestrichChief Strategy Officer NPC | John O’BrienPresident & CEO NPC (moderator) |
Thanks to the HIV+Hepatitis Policy Institute and CancerCare for making this webinar possible.
Register Now
After registering, you will receive a confirmation email containing information about joining the meeting via Zoom.
We hope you will join us for this important conversation.



